Cure
Overview
A look at how the state's biomedical institutions compare nationally, and where stronger connections to industry could accelerate innovation.
New York's research institutions produce some of the most cited biomedical science in the country, often on smaller budgets than their national peers. Using the Cure Innovation Index, this report follows that science from the lab toward the clinic and the market, and finds the state's advantage narrowing at the handoff to industry. It profiles institutions already bridging that gap and closes with practical steps for companies, investors, research institutions, and state leaders looking to strengthen those links.
